Chris Landon, Business Leader Image Guided Therapy Devices at Philips:
“IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”

Last year, Lunit INSIGHT MMG, Lunit’s AI-powered mammography analysis solution, was selected as the preferred AI technology for mammogram screening in the BSNSW State program. The selection of Lunit INSIGHT MMG was a global first, marking the beginning of a new era where national cancer screening organizations assess the operational role of AI solutions in maintaining and improving client outcomes.

“Our partnership with UCB highlights the potential of leveraging AI for improving care for many diseases, including osteoporosis” explains Richard Ljuhar, CEO at ImageBiopsy Lab.